Aberrant LncRNA Expression in Multiple Myeloma

Overview

Journal Oncol Res

Specialty Oncology

Date 2017 Dec 8

PMID 29212572

Citations 14

Authors

Hui Meng

Lei Han

Chun Hong

Jinya Ding

Qianchuan Huang

Affiliations

Soon will be listed here.

Abstract

Multiple myeloma (MM), a type of malignant tumor, is characterized by dysplasia of clonal plasma cells in the bone marrow. People with MM will have damaged organs or tissues due to secretion of large amounts of monoclonal immunoglobulin or fragments (M protein). Despite improved survivability by novel treatment strategies over the last decade, MM is still incurable by current therapies. Long noncoding RNAs (lncRNAs), with length of more than 200 nucleotides, have been reported to act as important regulators in many diseases, including MM. Recent studies have reported aberrant lncRNA expression in MM; these dysregulated lncRNAs can play oncogenic and/or tumor-suppressive roles in the development and progression of MM. In this article, we present a general overview on the role of lncRNAs in MM pathogenesis and discuss their potential as prognostic biomarkers and targets for treatment.

Citing Articles

binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy.

Mishra R, Thunuguntla P, Perkin A, Duraiyan D, Bagwill K, Gonzales S bioRxiv. 2024; .

PMID: 38979159 PMC: 11230414. DOI: 10.1101/2024.06.27.600975.

Potential Clinical Role of LncRNA miR503HG in Multiple Myeloma and its Effect on the Proliferation and Adhesion of Myeloma Cells.

Yin P, Zhou X Indian J Hematol Blood Transfus. 2024; 40(1):43-51.

PMID: 38312189 PMC: 10830954. DOI: 10.1007/s12288-023-01658-x.

The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma.

Nylund P, Garrido-Zabala B, Kalushkova A, Wiklund H Front Oncol. 2023; 13:1303677.

PMID: 38148842 PMC: 10750364. DOI: 10.3389/fonc.2023.1303677.

Expression of NEAT1 can be used as a predictor for Dex resistance in multiple myeloma patients.

Ren Y, Liu Y, He W, Zhao W, Pan J, Gao H BMC Cancer. 2023; 23(1):630.

PMID: 37407915 PMC: 10320976. DOI: 10.1186/s12885-023-11084-x.

Mechanism of Action of Decitabine in the Treatment of Acute Myeloid Leukemia by Regulating LINC00599.

Du F, Jin T, Wang L Anal Cell Pathol (Amst). 2023; 2023:2951519.

PMID: 36874552 PMC: 9977558. DOI: 10.1155/2023/2951519.

References

Li B, Chen P, Qu J, Shi L, Zhuang W, Fu J . Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J Biol Chem. 2014; 289(42):29365-75. PMC: 4200285. DOI: 10.1074/jbc.M114.572693. View

Faghihi M, Modarresi F, Khalil A, Wood D, Sahagan B, Morgan T . Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008; 14(7):723-30. PMC: 2826895. DOI: 10.1038/nm1784. View

Guo F, Jiao F, Song Z, Li S, Liu B, Yang H . Regulation of MALAT1 expression by TDP43 controls the migration and invasion of non-small cell lung cancer cells in vitro. Biochem Biophys Res Commun. 2015; 465(2):293-8. DOI: 10.1016/j.bbrc.2015.08.027. View

Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F . Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014; 281(7):1750-8. DOI: 10.1111/febs.12737. View

Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M . Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2010; 30(16):1956-62. PMC: 3230933. DOI: 10.1038/onc.2010.568. View

Zhuang W, Ge X, Yang S, Huang M, Zhuang W, Chen P . Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription. Stem Cells. 2015; 33(6):1985-97. DOI: 10.1002/stem.1989. View

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

Dey B, Mueller A, Dutta A . Long non-coding RNAs as emerging regulators of differentiation, development, and disease. Transcription. 2014; 5(4):e944014. PMC: 4581346. DOI: 10.4161/21541272.2014.944014. View

Avet-Loiseau H, Li J, Facon T, Brigaudeau C, Morineau N, Maloisel F . High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res. 1998; 58(24):5640-5. View

10.

Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J . Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis. 2002; 23(11):1885-95. DOI: 10.1093/carcin/23.11.1885. View

11.

Bernard D, Prasanth K, Tripathi V, Colasse S, Nakamura T, Xuan Z . A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J. 2010; 29(18):3082-93. PMC: 2944070. DOI: 10.1038/emboj.2010.199. View

12.

Pasmant E, Sabbagh A, Vidaud M, Bieche I . ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2010; 25(2):444-8. DOI: 10.1096/fj.10-172452. View

13.

Wu W, Zhang S, Li X, Xue M, Cao S, Chen W . Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One. 2013; 8(9):e73920. PMC: 3771932. DOI: 10.1371/journal.pone.0073920. View

14.

Lee J . Epigenetic regulation by long noncoding RNAs. Science. 2012; 338(6113):1435-9. DOI: 10.1126/science.1231776. View

15.

Romanuik T, Wang G, Morozova O, Delaney A, Marra M, Sadar M . LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Med Genomics. 2010; 3:43. PMC: 2956710. DOI: 10.1186/1755-8794-3-43. View

16.

Ellis B, Molloy P, Graham L . CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment. Front Genet. 2012; 3:270. PMC: 3509318. DOI: 10.3389/fgene.2012.00270. View

17.

Chang H, Qi X, Jiang A, Xu W, Young T, Reece D . 1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma. Bone Marrow Transplant. 2009; 45(1):117-21. DOI: 10.1038/bmt.2009.107. View

18.

Qiao H, Gao W, Huo J, Yang Z . Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev. 2013; 14(2):1077-82. DOI: 10.7314/apjcp.2013.14.2.1077. View

19.

Li X, Guo Y, De W . DNA methylation and microRNAs in cancer. World J Gastroenterol. 2012; 18(9):882-8. PMC: 3297046. DOI: 10.3748/wjg.v18.i9.882. View

20.

Mohamed A, Bentley G, Bonnett M, Zonder J, Al-Katib A . Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes. Am J Hematol. 2007; 82(12):1080-7. DOI: 10.1002/ajh.20998. View